Relative adrenal failure in intensive care: An identifiable problem requiring treatment?

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 15, Issue 4, 2001, Pages 513-531

  Beishuizen, Albertus ^a   Thijs, Lambertus G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ACTH stimulation test; Adrenal dysfunction; Corticostatin; Corticosteroid binding globulin; Corticosteroids; Cortisol; Cytokines; Eosinophilia; Glucocorticoid receptor; Hydrocortisone; Low dose; Macrophage migration inhibitory factor; Relative adrenal insufficiency; Sepsis; Septic shock

Indexed keywords

CATECHOLAMINE; CORTICOSTATIN; CORTICOSTEROID DERIVATIVE; CORTICOTROPIN; FLUDROCORTISONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; INTERLEUKIN 6; PLACEBO; PROLYLLEUCYLGLYCINAMIDE; STEROID; TRANSCORTIN; TUMOR NECROSIS FACTOR ALPHA; VASOPRESSIN;

ADAPTATION; ADRENAL CORTEX FUNCTION; ADRENAL INSUFFICIENCY; CLINICAL TRIAL; CORTICOTROPIN TEST; CRITICAL ILLNESS; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE RESISTANCE; DISEASE SEVERITY; DRUG EFFECT; DRUG MEGADOSE; DRUG RESPONSE; EOSINOPHILIA; HEMODYNAMICS; HOMEOSTASIS; HORMONE SUBSTITUTION; HORMONE SYNTHESIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPOPHYSIS ADRENAL SYSTEM; HYPOTENSION; INTENSIVE CARE; METABOLIC ACTIVATION; MULTIPLE ORGAN FAILURE; NEUROENDOCRINE SYSTEM; NONHUMAN; PATHOGENESIS; PROGNOSIS; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SEPSIS; SEPTIC SHOCK; STRESS; SURVIVAL; SYMPTOMATOLOGY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0035746526     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1053/beem.2001.0167     Document Type: Article

References (105)

1. Comparative studies on adrenal cortical function and cortisol metabolism in healthy subjects and in patients with shock due to infection
2. Variable adrenocortical function in acute medical illness
3. Spectrum of serum cortisol response to ACTH in ICU patients
4. Adrenocortical function: An indicator of severity of disease and survival in chronic critically ill patients
5. Adrenal functions in patients with sepsis
6. Corticosteroids in septic shock: Resurrection of the last rites?
7. Reversal of late septic shock with supraphysiologic doses of hydrocortisone
8. Hypothalamic-pituitary-adrenal insufficiency
9. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
10. Corticosteroid/antibiotic treatment of adrenalectomized dogs challenged with lethal E. coli
11. Corticosteroids and infections
12. Influence of sedation on mortality in critically ill multiple trauma patients
13. Variations in adrenocortical responsiveness during severe bacterial infections. Unrecognized adrenocortical insufficiency in severe bacterial infections
14. Adrenal failure in the critically ill
15. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: Possible role of endothelin and atrial natriuretic hormone
16. Evidence for adrenocortical adaptation to severe illness
17. Hormonal responses to graded surgical stress
18. Plasma cortisol is often decreased in patients treated in an intensive care unit
19. Plasma cortisol levels in patients with septic shock
20. Hypocortisolaemia and adrenocortical responsiveness at onset of septic shock
21. Drug therapy: Corticosteroid therapy in severe illness
22. Hypercortisolism in septic shock is not suppressible by dexamethasone infusion
23. Mechanism of adrenal insufficiency following trauma and severe hemorrhage: Role of hepatic 11beta-hydroxysteroid dehydrogenase
24. Adrenocortical function during septic shock
25. Responses of plasma adrenocorticotropic hormone, cortisol and cytokines during and after upper abdominal surgery
26. Inhibition of corticosteroid-binding globulin caused by a severe stressor is apparently mediated by the adrenal but not by glucocorticoid receptors
27. Serum depletion of corticosteroid binding activities, an early marker of human septic shock
28. Decreased immunoreactivity and binding activity of corticosteroid-binding globulin in serum in septic shock
29. Patterns of corticosteroid-binding globulin and free cortisol index during severe sepsis and multitrauma
30. A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils
31. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin
32. The use of free cortisol index for laboratory assessment of pituitary-adrenal function
33. Contribution of cortisol deficiency to septic shock
34. The hypothalamic-pituitary-adrenal axis in critical illness: Response to dexamethasone and corticotropin releasing hormone
35. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin
36. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: Altered response to corticotropin-releasing hormone
37. Glucocorticoid treatment of sepsis and acute respiratory distress syndrome: Time for a critical reappraisal
38. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids
39. Temperature-induced down-regulation of the glucocorticoid receptor in peripheral blood mononuclear leucocyte in patients with sepsis or septic shock
40. Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock
41. A syndrome produced by diverse nocuous agents
42. Adrenocortical function in critically ill patients 24 h after a single dose of etomidate
43. Cortisol response to corticotropin and survival in septic shock
44. Current concepts: Adrenal insufficiency
45. Occult hypoadrenalism in critically ill patients
46. Adrenal insufficiency occurring during septic shock: Incidence, outcome, and relationship to peripheral cytokine levels
47. A comparison of the adrenocortical response during septic shock and after complete recovery
48. What test for hypothalamic-pituitary-adrenocortical insufficiency?
49. Adrenal insufficiency in critically ill patients
50. Adrenocortical function in critical illness
51. Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve
52. Rapid adrenocorticotropic hormone test in practice. Retrospective review
53. Laboratory assessment of adrenal insufficiency
54. The short Synacthen test in acute hospital admissions
55. Plasma cortisol levels before and during 'low-dose' hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock
56. Sepsis-induced adrenal deficiency syndrome
57. The low dose (1 μg) ACTH stimulation test for assessment of the hypothalamo-pituitary-adrenal axis
58. Adrenocorticotropin stimulation test: Effects of basal cortisol level, time of day, and suggested new sensitive low dose test
59. The low dose (1-μg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency
60. Low dose (1 μg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease
61. Low-dose (1 μg) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: Sensitivity, specificity and accuracy in comparison with the high-dose (250 μg) test
62. Repetitive graded ACTH stimulation test for adrenal insufficiency
63. A test for adrenal cortical insufficiency
64. Relative eosinophilia and functional adrenal insufficiency in critically ill patients
65. Acute adrenal insufficiency presenting as shock after trauma and surgery: Three cases and review of the literature
66. Adrenal insufficiency in the surgical intensive care unit patient
67. Postoperative acute adrenal failure caused by transient corticotropin deficiency
68. Stress doses of glucocorticoids in catecholamine dependency: A new therapy for a new syndrome?
69. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment
70. Adrenal dysfunction in critical illness: A clinical entity that requires treatment?
71. The immune-hypothalamic-pituitary-adrenal axis
72. Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells
73. Distribution and characterization of immunoreactive corticostatin in the hypothalamic-pituitary-adrenal axis
74. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation
75. Secretion and metabolism of cortisol after injection of endotoxin
76. Mechanisms of adrenocortical depression during Escherichia coli shock
77. Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors
78. Isolation and mode of action of rabbit corticostatic (antiadrenocorticotropin) peptides
79. Quantification and characterization of ACTH-related peptides produced by human peripheral blood mononuclear cells
80. Relationships among plasma cortisol, adrenocorticotrophin, and severity of injury in recently injured patients
81. Adrenal insufficiency in high-risk surgical ICU patients
82. Adrenocortical response and cortisone replacement in systemic inflammatory response syndrome
83. Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness
84. Macrophage migration inhibitory factor (MIF): A glucocorticoid counter-regulator within the immune system
85. Study on glucocorticoid receptors during intestinal ischemia shock and septic shock
86. Effect of glucocorticoid receptor (GR) blockade on endotoxemia in rats
87. Acute and prolonged critical illness as different neuroendocrine paradigms
88. Adrenal insufficiency during the late stage of polymicrobial sepsis
89. Survival of primates in lethal septic shock following delayed treatment with steroid
90. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study
91. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock
92. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. The Veterans Administration Systemic Sepsis Cooperative Study Group
93. Steroid controversy in sepsis and septic shock: A meta-analysis
94. Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature
95. Abrupt hemodynamic improvement in late septic shock with physiological doses of glucocorticoids
96. Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study
97. Reversal of late septic shock with supraphysiologic doses of hydrocortisone
98. Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group
99. NF-kappaB activation
100. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions
101. Mediators of septic shock: New approaches for interrupting the endogenous inflammatory cascade
102. Effects of the combination of hydrocortisone and fludrocortisone on mortality in septic shock
103. Adrenocortical function in patients with ruptured aneurysm of the abdominal aorta
104. Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: Evidence of adrenal insufficiency